Cryo-Cell International, Inc. (CCEL)

Cryo-Cell International Balance Sheet

Financials in millions USD. Fiscal year is December - November.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020
Cash & Equivalents	0.56	0.41	1.7	8.26	10.36
Short-Term Investments	2.94	0.57	0.02	0.08	0.09
Trading Asset Securities	-	0.12	-	-	-
Cash & Short-Term Investments	3.5	1.1	1.72	8.34	10.45
Cash Growth	217.15%	-35.97%	-79.35%	-20.20%	40.36%
Receivables	7.31	6.58	6.04	5.25	6.32
Inventory	0.66	0.77	0.85	0.92	0.93
Prepaid Expenses	0.64	0.62	0.57	0.56	0.61
Other Current Assets	0.45	0.39	0.43	0.71	0.24
Total Current Assets	12.55	9.45	9.61	15.78	18.56
Property, Plant & Equipment	22.7	22.03	14.21	4.15	1.94
Long-Term Investments	-	0.31	0.31	0.31	0.31
Goodwill	1.94	1.94	1.94	1.94	1.94
Other Intangible Assets	0.92	0.99	15.15	16.21	1.53
Long-Term Deferred Tax Assets	20.8	20.49	13.74	12.01	10.36
Other Long-Term Assets	5.76	6.01	9.92	10.26	11.56
Total Assets	64.68	61.22	64.89	60.66	46.2
Accounts Payable	1.88	3.17	1.61	1.49	0.96
Accrued Expenses	5.81	3.74	3.24	3.06	1.94
Short-Term Debt	3.52	1.22	2.27	-	-
Current Portion of Long-Term Debt	0.17	0.17	0.15	1.9	3.1
Current Portion of Leases	0.43	0.23	0.3	0.31	0.28
Current Income Taxes Payable	-	1.43	0.34	-	0.96
Current Unearned Revenue	9.79	9.7	9.59	9.36	9.18
Other Current Liabilities	-	1.2	1.98	4.96	-
Total Current Liabilities	21.6	20.86	19.48	21.07	16.41
Long-Term Debt	8.31	8.43	8.58	-	2.84
Long-Term Leases	0.51	0.85	0.31	0.61	0.02
Long-Term Unearned Revenue	46.56	41.19	36	31.27	27.2
Other Long-Term Liabilities	0.92	0.92	2.04	3.52	2.38
Total Liabilities	77.89	72.25	66.41	56.48	48.87
Common Stock	0.15	0.15	0.15	0.15	0.14
Additional Paid-In Capital	44.27	43.41	42.6	41.59	36.58
Retained Earnings	-32.78	-31.16	-21.64	-16.74	-18.82
Treasury Stock	-24.86	-23.43	-22.63	-20.81	-20.56
Shareholders' Equity	-13.22	-11.03	-1.52	4.18	-2.67
Total Liabilities & Equity	64.68	61.22	64.89	60.66	46.2
Total Debt	12.93	10.9	11.61	2.82	6.24
Net Cash (Debt)	-9.44	-9.79	-9.89	5.52	4.21
Net Cash Growth	-	-	-	31.08%	-
Net Cash Per Share	-1.15	-1.17	-1.17	0.66	0.52
Filing Date Shares Outstanding	8.08	8.29	8.44	8.5	7.57
Total Common Shares Outstanding	8.08	8.29	8.5	8.56	7.55
Working Capital	-9.04	-11.41	-9.87	-5.29	2.14
Book Value Per Share	-1.64	-1.33	-0.18	0.49	-0.35
Tangible Book Value	-16.08	-13.96	-18.62	-13.97	-6.14
Tangible Book Value Per Share	-1.99	-1.68	-2.19	-1.63	-0.81
Buildings	-	11.22	11.22	1.51	-
Machinery	-	8.75	7.74	6.84	6.63
Construction In Progress	-	6.71	-	-	-
Leasehold Improvements	-	1.26	1.26	1.21	1.2

Source: S&P Capital IQ. Standard template. Financial Sources.